Findings persist even after controlling for adverse neighborhood conditions
Read More »DDW: Lower Risk for Obesity-Linked Cancer Seen With Bariatric Surgery
Prevalence rates lower for de novo breast cancer, colon cancer, liver cancer, pancreatic cancer, ovarian cancer, endometrial cancer
Read More »Intermittent Fasting + Time-Restricted Eating Beneficial for Those at Risk for T2DM
iTRE approach improves glucose tolerance more than calorie restriction in adults at risk for type 2 diabetes; however, at month 18, these differences were attenuated
Read More »Sugar-Sweetened Beverage Intake Linked to Mortality, CVD in T2D
Increased hazard ratio noted for all-cause mortality, CVD incidence and mortality for higher sugar-sweetened beverage intake
Read More »SARS-CoV-2 Infection Linked to Increased Risk for Diabetes
Fraction of incident diabetes cases attributable to SARS-CoV-2 infection was 3.41 percent overall, 4.75 percent among men
Read More »Bariatric Surgery Improves Many Diabetes Complications
Improvement seen in peripheral neuropathy, while cardiovascular autonomic neuropathy and retinopathy were stable
Read More »Later-Life Mortality Increased With Pregnancy Complications
Greater mortality risk seen in association with preterm induced labor for Black versus White participants
Read More »Diabetes and Cardiovascular Disease: Understanding the Connection and Who is Most at Risk
Diabetes is a chronic medical condition that affects millions of people around the world. The disease is characterized by elevated levels of glucose in the blood, which is caused by the body’s inability to properly use insulin. While diabetes is typically known for its effects on blood sugar levels, it …
Read More »Reviewing the Benefits of SGLT2 Inhibitors in Diabetes Treatment
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of medications that have been developed to treat type 2 diabetes. SGLT2 inhibitors work by blocking the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine and improved glucose control. The continued benefits of SGLT2 inhibitors …
Read More »Artificial Pancreas and Type 2 Diabetes
Diabetes is a chronic disease that affects millions of people worldwide, and it is estimated that over 90% of those diagnosed have type 2 diabetes. The disease occurs when the body is unable to produce or use insulin efficiently, leading to elevated blood sugar levels. One of the most innovative …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.